Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Analysis of T1c prostate cancers treated at very low prostate-specific antigen levels
International Braz J Urol, 11/06/09
Stephenson AJ et al. – The pathologic features and outcome of patients treated at low PSA levels are favorable and similar for patients with PSA < or = 2.5 versus 2.6–4.0. However, > 50% of the former have potentially biologically unimportant cancer. We failed to identify a therapeutic benefit to the diagnosis of cancers below accepted PSA thresholds for biopsy.
Related Articles
Should Prostate Specific Antigen be Adjusted for Body Mass Index? Data From the Baltimore Longitudinal Study of Aging
The Journal of Urology, 11/12/09
Relevance Score: 69%
Natural History of Persistently Elevated Prostate Specific Antigen After Radical Prostatectomy: Results From the SEARCH Database
The Journal of Urology, 10/16/09
Relevance Score: 69%
Men Older Than 70 Years Have Higher Risk Prostate Cancer and Poorer Survival in the Early and Late Prostate Specific Antigen Eras
The Journal of Urology, 10/21/09
Relevance Score: 68%
Prostate specific antigen for early detection of prostate cancer: longitudinal study
British Medical Journal, 10/08/09
Relevance Score: 67%
Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22r
Magnetic Resonance in Medicine, 10/09/09
Relevance Score: 66%
Today in Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Sacral Nerve Stimulation as a Treatment Modality for Intractable Neuropathic Testicular Pain
Pain Physician, 11/25/09
Bipolar transurethral resection of the prostate causes less bleeding than the monopolar technique: a single-centre randomized trial of 202 patients
BJU International, 11/25/09
Are patients with non-muscle-invasive bladder cancer a suitable population for a lung cancer screening trial
BJU International, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


